Covered recipient · General Payments record
ORLANDO PORTAL
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,310.63
- Reported across 118 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $297.63 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $91.50 | 7 |
| Lilly USA, LLC | $63.02 | 3 |
| ABBVIE INC. | $35.98 | 2 |
| Teva Pharmaceuticals USA, Inc. | $26.00 | 1 |
| Otsuka America Pharmaceutical, Inc. | $24.63 | 1 |
| Exact Sciences Corporation | $23.13 | 1 |
| Phathom Pharmaceuticals, Inc. | $18.07 | 1 |
| SHIELD THERAPEUTICS INC | $15.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.01 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105295425 | CMS |
| ABBVIE INC. | $15.97 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105295429 | CMS |
| Exact Sciences Corporation | $23.13 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114838963 | CMS |
| Lilly USA, LLC | $17.85 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135301910 | CMS |
| Lilly USA, LLC | $24.19 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135258956 | CMS |
| Lilly USA, LLC | $20.98 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135311679 | CMS |
| Otsuka America Pharmaceutical, Inc. | $24.63 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118962839 | CMS |
| PFIZER INC. | $17.68 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131531278 | CMS |
| PFIZER INC. | $1.89 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131584148 | CMS |
| PFIZER INC. | $4.86 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131598630 | CMS |
| PFIZER INC. | $16.10 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131619230 | CMS |
| PFIZER INC. | $24.19 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132086970 | CMS |
| PFIZER INC. | $6.22 | 10/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132074181 | CMS |
| PFIZER INC. | $20.56 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131007333 | CMS |
| Phathom Pharmaceuticals, Inc. | $18.07 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151111506 | CMS |
| SHIELD THERAPEUTICS INC | $15.30 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150119018 | CMS |
| Teva Pharmaceuticals USA, Inc. | $26.00 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151717638 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.